Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thai Ministry, U.S. Industries Agree To Compulsory License Compromise

This article was originally published in PharmAsia News

Executive Summary

Thai officials and U.S. industries have agreed in principle to make some drugs more accessible to Thais short of imposing compulsory licenses. Thailand's Commerce Ministry met with groups representing U.S. drug makers and biotech companies. The three parties agreed to cooperate on Thai research and development to give the nation the capability of producing its own less-expensive quality drugs. In exchange, the government would refrain from imposing compulsory licensing except as a last resort. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts